Literature DB >> 21780097

Molecular model of human heparanase with proposed binding mode of a heparan sulfate oligosaccharide and catalytic amino acids.

Nicolas Sapay1, Eric Cabannes, Maurice Petitou, Anne Imberty.   

Abstract

Heparan sulfate is abundantly present in the extracellular matrix. As other glycosaminoglycans, it is synthesized in the Golgi apparatus and then exposed on the cell surface. The glucuronidase activity of human heparanase plays a major role in the structural remodeling of the extracellular matrix, which underlies cell migration, hence tumor invasion. Heparanase is therefore a major target for anti-cancer treatment. Several inhibitors of its enzymatic activity have been synthesized. However, their design is limited by the absence of experimental structure of the protein. Homology modeling is proposed based on the structure of the endoxylanase from Penicillium simplicissimum co-crystallized with a series of xylan oligosaccharide. The new heparanase model is consistent with the few experimental data suited for the validation of such work. Furthermore, the presence of natural substrates in the template structure allowed us to propose a binding model for a hydrolyzed heparin sulfate pentasaccharide. Several lysine residues have been identified to play a key role in binding to the anionic polysaccharide substrate. In addition, two phenylalanine residues are also potentially important for the interaction with the substrate. The enzymatic mechanism investigated in the light of this new model allows for the proposal of several amino acids that can influence the protonation state of the nucleophile and the proton donor.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21780097     DOI: 10.1002/bip.21696

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  11 in total

1.  Functional and structural characterization of a heparanase.

Authors:  Lisa Bohlmann; Gregory D Tredwell; Xing Yu; Chih-Wei Chang; Thomas Haselhorst; Moritz Winger; Jeffrey C Dyason; Robin J Thomson; Joe Tiralongo; Ifor R Beacham; Helen Blanchard; Mark von Itzstein
Journal:  Nat Chem Biol       Date:  2015-11-02       Impact factor: 15.040

2.  Structural and biochemical characterization of glycoside hydrolase family 79 β-glucuronidase from Acidobacterium capsulatum.

Authors:  Mari Michikawa; Hitomi Ichinose; Mitsuru Momma; Peter Biely; Seino Jongkees; Makoto Yoshida; Toshihisa Kotake; Yoichi Tsumuraya; Stephen G Withers; Zui Fujimoto; Satoshi Kaneko
Journal:  J Biol Chem       Date:  2012-02-24       Impact factor: 5.157

3.  The potential of heparanase as a therapeutic target in cancer.

Authors:  Claudio Pisano; Israel Vlodavsky; Neta Ilan; Franco Zunino
Journal:  Biochem Pharmacol       Date:  2014-02-22       Impact factor: 5.858

4.  Demystifying the pH dependent conformational changes of human heparanase pertaining to structure-function relationships: an in silico approach.

Authors:  Hemavathy Nagarajan; Umashankar Vetrivel
Journal:  J Comput Aided Mol Des       Date:  2018-07-06       Impact factor: 3.686

5.  Deciphering mode of action of heparanase using structurally defined oligosaccharides.

Authors:  Sherket Peterson; Jian Liu
Journal:  J Biol Chem       Date:  2012-08-14       Impact factor: 5.157

6.  Mechanisms of heparanase inhibition by the heparan sulfate mimetic PG545 and three structural analogues.

Authors:  Edward Hammond; Paul Handley; Keith Dredge; Ian Bytheway
Journal:  FEBS Open Bio       Date:  2013-08-02       Impact factor: 2.693

Review 7.  Heparanase: A Challenging Cancer Drug Target.

Authors:  Deirdre R Coombe; Neha S Gandhi
Journal:  Front Oncol       Date:  2019-11-28       Impact factor: 6.244

8.  Synthesis of a pseudo-disaccharide library and its application to the characterisation of the heparanase catalytic site.

Authors:  Victoria Vinader; Mohamed H Haji-Abdullahi; L H Patterson; Kamyar Afarinkia
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

Review 9.  The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.

Authors:  Edward Hammond; Ashwani Khurana; Viji Shridhar; Keith Dredge
Journal:  Front Oncol       Date:  2014-07-24       Impact factor: 6.244

10.  Kinetic analysis and molecular modeling of the inhibition mechanism of roneparstat (SST0001) on human heparanase.

Authors:  Daniele Pala; Silvia Rivara; Marco Mor; Ferdinando Maria Milazzo; Giuseppe Roscilli; Emiliano Pavoni; Giuseppe Giannini
Journal:  Glycobiology       Date:  2016-01-13       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.